Does FLUVASTATIN Cause Basal cell carcinoma? 33 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Basal cell carcinoma have been filed in association with FLUVASTATIN (FLUVASTATIN SODIUM ER). This represents 1.8% of all adverse event reports for FLUVASTATIN.
33
Reports of Basal cell carcinoma with FLUVASTATIN
1.8%
of all FLUVASTATIN reports
0
Deaths
33
Hospitalizations
How Dangerous Is Basal cell carcinoma From FLUVASTATIN?
Of the 33 reports, 33 (100.0%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FLUVASTATIN. However, 33 reports have been filed with the FAERS database.
What Other Side Effects Does FLUVASTATIN Cause?
Myalgia (577)
Dizziness (304)
Arthralgia (263)
Diarrhoea (260)
Headache (260)
Pruritus (257)
Dyspnoea (234)
Fall (234)
Insomnia (234)
Fatigue (231)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which FLUVASTATIN Alternatives Have Lower Basal cell carcinoma Risk?
FLUVASTATIN vs FLUVOXAMINE
FLUVASTATIN vs FOLATE
FLUVASTATIN vs FOLIC ACID
FLUVASTATIN vs FOLINIC ACID
FLUVASTATIN vs FOLLICLE STIMULATING HORMONE BETA POLYPEPTIDE\LUTROPIN ALFA